Korro Bio Inc
(KRRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -18,746 | -19,168 | -20,237 | N/A |
| Depreciation Amortization | 813 | 654 | 531 | N/A |
| Accounts payable and accrued liabilities | -644 | 869 | -231 | N/A |
| Other Working Capital | 48,646 | 819 | 276 | N/A |
| Other Operating Activity | 4,147 | -198 | 5,047 | 0 |
| Operating Cash Flow | $34,216 | $-17,024 | $-14,614 | $N/A |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,064 | -436 | -1,863 | N/A |
| Purchase Of Investment | -282,618 | N/A | N/A | N/A |
| Sale Of Investment | 265,421 | N/A | N/A | N/A |
| Investing Cash Flow | $-18,261 | $-436 | $-1,863 | $N/A |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 5,000 | N/A | N/A |
| Common Stock Issued | 80,062 | 73 | 27 | N/A |
| Other Financing Activity | 61,953 | 36,639 | 27,951 | 0 |
| Financing Cash Flow | $142,015 | $41,712 | $27,978 | $N/A |
| Beginning Cash Position | 42,289 | 17,937 | 6,436 | N/A |
| End Cash Position | 200,259 | 42,189 | 17,937 | N/A |
| Net Cash Flow | $157,970 | $24,252 | $11,501 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | 34,216 | -17,024 | -14,614 | N/A |
| Capital Expenditure | -1,064 | -436 | -1,863 | N/A |
| Free Cash Flow | 33,152 | -17,460 | -16,477 | 0 |